UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 332

Sortiert nach

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

BMC cancer, 2021-01, Vol.21 (1), p.19-19, Article 19

2021

Volltextzugriff (PDF)

Prognostic effects of histology‐based tumour microenvironment scores in resected distal bile duct cancer

Histopathology, 2020-09, Vol.77 (3), p.402-412

2020

Volltextzugriff (PDF)

Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes

Cancers, 2022-11, Vol.14 (22), p.5600

2022

Volltextzugriff (PDF)

Enhanced Risk Stratification in Early-Stage Endometrial Cancer: Integrating POLE through Droplet Digital PCR and L1CAM

Cancers, 2023-10, Vol.15 (19), p.4899

2023

Volltextzugriff (PDF)

EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer

Cancers, 2022-12, Vol.15 (1), p.124

2022

Volltextzugriff (PDF)

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

The lancet oncology, 2008-06, Vol.9 (6), p.533-542

2008

Volltextzugriff (PDF)

Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis

Clinical & experimental metastasis, 2020-04, Vol.37 (2), p.353-363

2020

Volltextzugriff (PDF)

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07

Thoracic cancer, 2020-12, Vol.11 (12), p.3482-3489

2020

Volltextzugriff (PDF)

How to start niraparib in real-world Asian ovarian cancer patients?

Journal of Gynecologic Oncology, 2021, 32(2), , pp.1-4

Hong, Sook Hee

2021

Volltextzugriff (PDF)

The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study

BMC cancer, 2019-11, Vol.19 (1), p.1100-1100, Article 1100

2019

Volltextzugriff (PDF)

Hippo pathway as another oncogenic mediator to promote immune evasion by PD-L1 signaling

Journal of thoracic disease, 2019-03, Vol.11 (Suppl 3), p.S318-S321

Hong, Sook-Hee

2019

Volltextzugriff (PDF)

High-resolution genomic configuration of FGFR rearrangements dictates the therapeutic vulnerability of squamous cell lung cancers

Translational lung cancer research, 2024-02, Vol.13 (2), p.236-239

2024

Volltextzugriff (PDF)

The Prognostic Value of Sex-Determining Region Y-Box 2 and CD8+ Tumor-Infiltrating Lymphocytes in Limited-Stage Small-Cell Lung Cancer

Oncology, 2021-07, Vol.99 (8), p.528-538

2021

Volltextzugriff (PDF)

Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys

Journal of pain and symptom management, 2011, Vol.41 (1), p.93-103

2011

Volltextzugriff (PDF)

Diffuse pleural thickening with nodularity in a healthy young woman

The Korean Journal of Internal Medicine, 2023, 38(3), , pp.444-445

2023

Volltextzugriff (PDF)

Prevalence of human papillomavirus infection in women in Busan, South Korea

International journal of cancer, 2003-01, Vol.103 (3), p.413-421

2003

Volltextzugriff (PDF)

Next generation sequencing can be helpful in histologic diagnosis: A case report of metastatic breast cancer mimicking atypical carcinoid tumor of lung

Pathology, research and practice, 2020-05, Vol.216 (5), p.152835, Article 152835

2020

Volltextzugriff (PDF)

Effect of total intravenous versus inhalation anesthesia on long-term oncological outcomes in patients undergoing curative resection for early-stage non-small cell lung cancer: a retrospective cohort study

Korean Journal of Anesthesiology, 2023, 76(4), , pp.336-347

2023

Volltextzugriff (PDF)

Changes in PD-L1 expression according to tumor infiltrating lymphocytes of acquired EGFR-TKI resistant EGFR-mutant non-small-cell lung cancer

Oncotarget, 2017-12, Vol.8 (64), p.107630-107639

2017

Volltextzugriff (PDF)

Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival

Pathology, research and practice, 2018-03, Vol.214 (3), p.335-342

2018

Volltextzugriff (PDF)

Impact of Epidermal Growth Factor Receptor Mutation on Clinical Outcomes of Nintedanib Plus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer from the Korean Named Patient Program

Oncology, 2019-01, Vol.96 (1), p.51-58

2019

Volltextzugriff (PDF)

Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma

Diseases of the colon & rectum, 2002-06, Vol.45 (6), p.750-755

2002

Volltextzugriff (PDF)

Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma

Annals of surgical oncology, 2002-01, Vol.9 (1), p.13-19

2002

Volltextzugriff (PDF)

Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Radiation oncology journal , 2019, 37(3), , pp.166-175

2019

Volltextzugriff (PDF)

1 – 25 von 332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(321)

Publikationsform

Sprache

Englisch
(285)
Koreanisch
(47)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

Prognostic effects of histology‐based tumour microenvironment scores in resected distal bile duct cancer

Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes

Enhanced Risk Stratification in Early-Stage Endometrial Cancer: Integrating POLE through Droplet Digital PCR and L1CAM

Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression

EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07

How to start niraparib in real-world Asian ovarian cancer patients?

The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study

Hippo pathway as another oncogenic mediator to promote immune evasion by PD-L1 signaling

High-resolution genomic configuration of FGFR rearrangements dictates the therapeutic vulnerability of squamous cell lung cancers

The Prognostic Value of Sex-Determining Region Y-Box 2 and CD8+ Tumor-Infiltrating Lymphocytes in Limited-Stage Small-Cell Lung Cancer

Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys

Diffuse pleural thickening with nodularity in a healthy young woman

Prevalence of human papillomavirus infection in women in Busan, South Korea

Next generation sequencing can be helpful in histologic diagnosis: A case report of metastatic breast cancer mimicking atypical carcinoid tumor of lung

Effect of total intravenous versus inhalation anesthesia on long-term oncological outcomes in patients undergoing curative resection for early-stage non-small cell lung cancer: a retrospective cohort study

Changes in PD-L1 expression according to tumor infiltrating lymphocytes of acquired EGFR-TKI resistant EGFR-mutant non-small-cell lung cancer

Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival

Impact of Epidermal Growth Factor Receptor Mutation on Clinical Outcomes of Nintedanib Plus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer from the Korean Named Patient Program

Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma

Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma

Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Suchergebnisse filtern